Albuterol
Salbutamol may increase the QTc-prolonging activities of Ibutilide.
Alfuzosin
Alfuzosin may increase the QTc-prolonging activities of Ibutilide.
Amantadine
Amantadine may increase the QTc-prolonging activities of Ibutilide.
Advertisement
Amiodarone
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Amiodarone.
Amitriptyline
Amitriptyline may increase the QTc-prolonging activities of Ibutilide.
Amoxapine
Amoxapine may increase the QTc-prolonging activities of Ibutilide.
Advertisement
Anagrelide
The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Ibutilide.
Apomorphine
Apomorphine may increase the QTc-prolonging activities of Ibutilide.
Arformoterol
Arformoterol may increase the QTc-prolonging activities of Ibutilide.
Advertisement
Aripiprazole
Aripiprazole may increase the QTc-prolonging activities of Ibutilide.
Arsenic Trioxide
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Arsenic trioxide.
Artemether
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Artemether.
Asenapine
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Asenapine.
Atazanavir
Atazanavir may increase the QTc-prolonging activities of Ibutilide.
Atomoxetine
Atomoxetine may increase the QTc-prolonging activities of Ibutilide.
Azithromycin
Azithromycin may increase the QTc-prolonging activities of Ibutilide.
Bedaquiline
Bedaquiline may increase the QTc-prolonging activities of Ibutilide.
Bortezomib
Bortezomib may increase the QTc-prolonging activities of Ibutilide.
Buserelin
Buserelin may increase the QTc-prolonging activities of Ibutilide.
Ceritinib
Ceritinib may increase the QTc-prolonging activities of Ibutilide.
Chloroquine
Chloroquine may increase the QTc-prolonging activities of Ibutilide.
Chlorpromazine
Chlorpromazine may increase the QTc-prolonging activities of Ibutilide.
Ciprofloxacin
Ciprofloxacin may increase the QTc-prolonging activities of Ibutilide.
Cisapride
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Cisapride.
Citalopram
The risk or severity of QTc prolongation can be increased when Citalopram is combined with Ibutilide.
Clarithromycin
Clarithromycin may increase the QTc-prolonging activities of Ibutilide.
Clomipramine
Clomipramine may increase the QTc-prolonging activities of Ibutilide.
Clozapine
Clozapine may increase the QTc-prolonging activities of Ibutilide.
Crizotinib
Crizotinib may increase the QTc-prolonging activities of Ibutilide.
Dabrafenib
Dabrafenib may increase the QTc-prolonging activities of Ibutilide.
Dasatinib
Dasatinib may increase the QTc-prolonging activities of Ibutilide.
Dasatinib Anhydrous
Dasatinib may increase the QTc-prolonging activities of Ibutilide.
Degarelix
Degarelix may increase the QTc-prolonging activities of Ibutilide.
Desflurane
Desflurane may increase the QTc-prolonging activities of Ibutilide.
Desipramine
Desipramine may increase the QTc-prolonging activities of Ibutilide.
Deutetrabenazine
Ibutilide may increase the QTc-prolonging activities of Deutetrabenazine.
Diphenhydramine
Diphenhydramine may increase the QTc-prolonging activities of Ibutilide.
Disopyramide
The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Ibutilide.
Dofetilide
The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Ibutilide.
Dolasetron
Dolasetron may increase the QTc-prolonging activities of Ibutilide.
Domperidone
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Domperidone.
Doxepin
Doxepin may increase the QTc-prolonging activities of Ibutilide.
Dronedarone
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Dronedarone.
Droperidol
Droperidol may increase the QTc-prolonging activities of Ibutilide.
Eliglustat
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Eliglustat.
Eribulin
Eribulin may increase the QTc-prolonging activities of Ibutilide.
Erythromycin
Erythromycin may increase the QTc-prolonging activities of Ibutilide.
Escitalopram
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Escitalopram.
Ezogabine
Ezogabine may increase the QTc-prolonging activities of Ibutilide.
Famotidine
Famotidine may increase the QTc-prolonging activities of Ibutilide.
Felbamate
Felbamate may increase the QTc-prolonging activities of Ibutilide.
Fingolimod
Fingolimod may increase the arrhythmogenic activities of Ibutilide.
Flecainide
Flecainide may increase the QTc-prolonging activities of Ibutilide.
Fluconazole
Fluconazole may increase the QTc-prolonging activities of Ibutilide.
Fluoxetine
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Fluoxetine.
Flupenthixol
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Flupentixol.
Formoterol
Formoterol may increase the QTc-prolonging activities of Ibutilide.
Foscarnet
Foscarnet may increase the QTc-prolonging activities of Ibutilide.
Gadobenate
Gadobenic acid may increase the QTc-prolonging activities of Ibutilide.
Galantamine
Galantamine may increase the QTc-prolonging activities of Ibutilide.
Gemifloxacin
Gemifloxacin may increase the QTc-prolonging activities of Ibutilide.
Gemifloxacin Mesylate
Gemifloxacin may increase the QTc-prolonging activities of Ibutilide.
Goserelin
Goserelin may increase the QTc-prolonging activities of Ibutilide.
Granisetron
Granisetron may increase the QTc-prolonging activities of Ibutilide.
Haloperidol
Haloperidol may increase the QTc-prolonging activities of Ibutilide.
Histrelin
Histrelin may increase the QTc-prolonging activities of Ibutilide.
Hydroxyzine
Hydroxyzine may increase the QTc-prolonging activities of Ibutilide.
Ibandronate
Ibandronate may increase the QTc-prolonging activities of Ibutilide.
Ibandronic Acid
Ibandronate may increase the QTc-prolonging activities of Ibutilide.
Iloperidone
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Iloperidone.
Imipramine
Imipramine may increase the QTc-prolonging activities of Ibutilide.
Indacaterol
Indacaterol may increase the QTc-prolonging activities of Ibutilide.
Indapamide
Indapamide may increase the QTc-prolonging activities of Ibutilide.
Isoflurane
Isoflurane may increase the QTc-prolonging activities of Ibutilide.
Isradipine
Isradipine may increase the QTc-prolonging activities of Ibutilide.
Itraconazole
Itraconazole may increase the QTc-prolonging activities of Ibutilide.
Ivabradine
Ibutilide may increase the QTc-prolonging activities of Ivabradine.
Ketoconazole
Ketoconazole may increase the QTc-prolonging activities of Ibutilide.
Lapatinib
Lapatinib may increase the QTc-prolonging activities of Ibutilide.
Lenvatinib
Lenvatinib may increase the QTc-prolonging activities of Ibutilide.
Lenvatinib Mesylate
Lenvatinib may increase the QTc-prolonging activities of Ibutilide.
Leuprolide
Leuprolide may increase the QTc-prolonging activities of Ibutilide.
Levofloxacin
Levofloxacin may increase the QTc-prolonging activities of Ibutilide.
Levofloxacin Anhydrous
Levofloxacin may increase the QTc-prolonging activities of Ibutilide.
Lidocaine
Lidocaine may increase the arrhythmogenic activities of Ibutilide.
Lithium
Lithium may increase the QTc-prolonging activities of Ibutilide.
Lithium Cation
Lithium may increase the QTc-prolonging activities of Ibutilide.
Lopinavir
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Lopinavir.
Lumefantrine
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Lumefantrine.
Macimorelin
Ibutilide may increase the QTc-prolonging activities of Macimorelin.
Maprotiline
Maprotiline may increase the QTc-prolonging activities of Ibutilide.
Mefloquine
Mefloquine may increase the QTc-prolonging activities of Ibutilide.
Methadone
Methadone may increase the QTc-prolonging activities of Ibutilide.
Methotrimeprazine
Methotrimeprazine may increase the QTc-prolonging activities of Ibutilide.
Metoclopramide
Metoclopramide may increase the QTc-prolonging activities of Ibutilide.
Metronidazole
Metronidazole may increase the QTc-prolonging activities of Ibutilide.
Mifepristone
Ibutilide may increase the QTc-prolonging activities of Mifepristone.
Mirabegron
Mirabegron may increase the QTc-prolonging activities of Ibutilide.
Mirtazapine
Mirtazapine may increase the QTc-prolonging activities of Ibutilide.
Moexipril
Moexipril may increase the QTc-prolonging activities of Ibutilide.
Moxifloxacin
Moxifloxacin may increase the QTc-prolonging activities of Ibutilide.
Nelfinavir
Nelfinavir may increase the QTc-prolonging activities of Ibutilide.
Nicardipine
Nicardipine may increase the QTc-prolonging activities of Ibutilide.
Nilotinib
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Nilotinib.
Norfloxacin
Norfloxacin may increase the QTc-prolonging activities of Ibutilide.
Nortriptyline
Nortriptyline may increase the QTc-prolonging activities of Ibutilide.
Octreotide
Octreotide may increase the QTc-prolonging activities of Ibutilide.
Ofloxacin
Ofloxacin may increase the QTc-prolonging activities of Ibutilide.
Olanzapine
Olanzapine may increase the QTc-prolonging activities of Ibutilide.
Olodaterol
Olodaterol may increase the QTc-prolonging activities of Ibutilide.
Ondansetron
Ondansetron may increase the QTc-prolonging activities of Ibutilide.
Oxytocin
Oxytocin may increase the QTc-prolonging activities of Ibutilide.
Paliperidone
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Paliperidone.
Panobinostat
Panobinostat may increase the QTc-prolonging activities of Ibutilide.
Paroxetine
Paroxetine may increase the QTc-prolonging activities of Ibutilide.
Pasireotide
Pasireotide may increase the QTc-prolonging activities of Ibutilide.
Pazopanib
Pazopanib may increase the QTc-prolonging activities of Ibutilide.
Pentamidine
Pentamidine may increase the QTc-prolonging activities of Ibutilide.
Perflutren
Perflutren may increase the QTc-prolonging activities of Ibutilide.
Pimozide
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Pimozide.
Posaconazole
Posaconazole may increase the QTc-prolonging activities of Ibutilide.
Primaquine
Primaquine may increase the QTc-prolonging activities of Ibutilide.
Procainamide
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Procainamide.
Promazine
Promazine may increase the QTc-prolonging activities of Ibutilide.
Promethazine
Promethazine may increase the QTc-prolonging activities of Ibutilide.
Propafenone
Propafenone may increase the arrhythmogenic activities of Ibutilide.
Propofol
Propofol may increase the QTc-prolonging activities of Ibutilide.
Protriptyline
Protriptyline may increase the QTc-prolonging activities of Ibutilide.
Quetiapine
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Quetiapine.
Quinidine
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Quinidine.
Quinine
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Quinine.
Ranolazine
Ranolazine may increase the QTc-prolonging activities of Ibutilide.
Ribociclib
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Ibutilide.
Rilpivirine
Rilpivirine may increase the QTc-prolonging activities of Ibutilide.
Risperidone
Risperidone may increase the QTc-prolonging activities of Ibutilide.
Ritonavir
Ritonavir may increase the QTc-prolonging activities of Ibutilide.
Salmeterol
Salmeterol may increase the QTc-prolonging activities of Ibutilide.
Saquinavir
Saquinavir may increase the QTc-prolonging activities of Ibutilide.
Saquinavir Mesylate
Saquinavir may increase the QTc-prolonging activities of Ibutilide.
Sertraline
Sertraline may increase the QTc-prolonging activities of Ibutilide.
Sevoflurane
Sevoflurane may increase the QTc-prolonging activities of Ibutilide.
Solifenacin
Solifenacin may increase the QTc-prolonging activities of Ibutilide.
Sorafenib
Sorafenib may increase the QTc-prolonging activities of Ibutilide.
Sotalol
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Sotalol.
Sulfamethoxazole
Sulfamethoxazole may increase the QTc-prolonging activities of Ibutilide.
Sulfisoxazole
Sulfisoxazole may increase the QTc-prolonging activities of Ibutilide.
Sunitinib
Sunitinib may increase the QTc-prolonging activities of Ibutilide.
Tamoxifen
Tamoxifen may increase the QTc-prolonging activities of Ibutilide.
Telavancin
Telavancin may increase the QTc-prolonging activities of Ibutilide.
Telithromycin
Telithromycin may increase the QTc-prolonging activities of Ibutilide.
Terbutaline
Terbutaline may increase the QTc-prolonging activities of Ibutilide.
Terbutaline Sulfate
Terbutaline may increase the QTc-prolonging activities of Ibutilide.
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Tetrabenazine.
Thioridazine
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Thioridazine.
Thiothixene
Thiothixene may increase the QTc-prolonging activities of Ibutilide.
Tizanidine
Tizanidine may increase the QTc-prolonging activities of Ibutilide.
Tolterodine
Tolterodine may increase the QTc-prolonging activities of Ibutilide.
Toremifene
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Toremifene.
Trazodone
Trazodone may increase the QTc-prolonging activities of Ibutilide.
Treprostinil
Treprostinil may increase the QTc-prolonging activities of Ibutilide.
Trimethoprim
Trimethoprim may increase the QTc-prolonging activities of Ibutilide.
Trimipramine
Trimipramine may increase the QTc-prolonging activities of Ibutilide.
Triptorelin
Triptorelin may increase the QTc-prolonging activities of Ibutilide.
Vandetanib
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Vandetanib.
Vardenafil
Vardenafil may increase the QTc-prolonging activities of Ibutilide.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Ibutilide.
Venlafaxine
Venlafaxine may increase the QTc-prolonging activities of Ibutilide.
Vilanterol
Vilanterol may increase the QTc-prolonging activities of Ibutilide.
Voriconazole
Voriconazole may increase the QTc-prolonging activities of Ibutilide.
Vorinostat
Vorinostat may increase the QTc-prolonging activities of Ibutilide.
Ziprasidone
The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Ibutilide.
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Zuclopenthixol.
